LEADER 04335nam  22006255  450 
001 9910253915003321
005 20200702001644.0
010   $a3-319-53880-2
024 7 $a10.1007/978-3-319-53880-8
035   $a(CKB)3710000001177745
035   $a(DE-He213)978-3-319-53880-8
035   $a(MiAaPQ)EBC4845056
035   $a(PPN)200514687
035   $a(EXLCZ)993710000001177745
100   $a20170421d2017      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiotechnology and Production of Anti-Cancer Compounds  /$fedited by Sonia Malik
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017.
215   $a1 online resource (XV, 328 p. 53 illus., 36 illus. in color.) 
311   $a3-319-53879-9 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aChapter 1 Medicinal Plants: Ethno-Uses to Biotechnology Era -- Chapter 2 How Plants Can Contribute to the Supply of Anti-Cancer Compounds -- Chapter 3 Cancer and Biotechnology: A Matchup that Should Never Slowdown -- Chapter 4 Plant Derived Compounds with Anti-Cancer Properties: From Folklore to Practice -- Chapter 5 Anticancer Drugs from Plants -- Chapter 6 Cambial Meristematic Cells: A Sustainable Platform for the Production of Plant-Derived Anti-Cancer Crugs -- Chapter 7 Family Fabaceae: A Boon for Cancer Therapy -- Chapter 8 Small Cells For Big Ideas: The Cytotoxic Podophyllotoxin And The Long Journey In Discovering Its Biosynthetic Pathway -- Chapter 9 Hairy Root Culture for the Production of Useful Secondary Metabolites -- Chapter 10 Edible Mushrooms and Their In Vitro Culture as a Source of Anticancer Compounds -- Chapter 11 Genomics and Artificial Intelligence Working Together in Drugs Discovery and Repositioning: The Advent of Adaptive Pharmacogenomics in Glioblastoma and Chronic Arterial Inflammation Therapies -- Chapter 12 A Multiscale Haemorheological Computer-based Model of Chronic Inflammation: an in-Depth Investigation of Erythrocytes-driven Flow Characteristics in Atheroma Development.
330   $aThis book discusses cancers and the resurgence of public interest in plant-based and herbal drugs. It also describes ways of obtaining anti-cancer drugs from plants and improving their production using biotechnological techniques. It presents methods such as cell culture, shoot and root culture, hairy root culture, purification of plant raw materials, genetic engineering, optimization of culture conditions as well as metabolic engineering with examples of successes like taxol, shikonin, ingenol mebutate and podophylotoxin. In addition, it describes the applications and limitations of large-scale production of anti-cancer compounds using biotechnological means. Lastly, it discusses future economical and eco-friendly strategies for obtaining anti-cancer compounds using biotechnology.
606   $aPlant breeding
606   $aCell culture
606   $aNatural resources
606   $aPharmacology
606   $aCancer$xResearch
606   $aPlant Breeding/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/L24060
606   $aCell Culture$3https://scigraph.springernature.com/ontologies/product-market-codes/L16020
606   $aNatural Resources$3https://scigraph.springernature.com/ontologies/product-market-codes/U39000
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
615  0$aPlant breeding.
615  0$aCell culture.
615  0$aNatural resources.
615  0$aPharmacology.
615  0$aCancer$xResearch.
615 14$aPlant Breeding/Biotechnology.
615 24$aCell Culture.
615 24$aNatural Resources.
615 24$aPharmacology/Toxicology.
615 24$aCancer Research.
676   $a631.52
676   $a660.6
702   $aMalik$b Sonia$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910253915003321
996   $aBiotechnology and Production of Anti-Cancer Compounds$92110402
997   $aUNINA